Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
Baron Health Care Fund Neal Kaufman | “Doximity, Inc. detracted from performance as the company issued disappointing guidance for the next two quarters. Client discussions indicated uncertainty around how recent policy changes may affect annual budgets, prompting management to take a more measured approach to revenue yet to be booked. Limited visibility and increased competition from emerging peers further pressured sentiment. Given these dynamics, we exited the position. BSD Analysis: Doximity owns a verified physician network that is extraordinarily hard to replicate. Engagement remains high because the platform sits inside daily clinical workflows, not social feeds. Advertising budgets fluctuate, but physician attention does not. Investors fixate on growth deceleration and miss margin durability. Hospitals and pharma pay for trusted access, not impressions. The business is asset-light and throws off cash. This is professional attention monetized efficiently, not adtech hype.” | BEAR | Q4 2025 Dec 31, 2025 | View Pitch |
Meridian Growth Fund ArrowMark Colorado Holdings, LLC | “Doximity, Inc. operates a cloud-based digital platform for medical professionals, often described as the “LinkedIn for healthcare.” Its suite of tools supports patient care, telemedicine, clinical news, research, and career development, reaching approximately 80% of U.S. physicians. Despite reporting solid quarterly results, shares declined following guidance that fell short of consensus expectations, reflecting moderation in projected revenue growth and uncertainty around healthcare and pharmaceutical spending. BSD Analysis: Doximity owns a rare asset: a verified, engaged physician network with minimal churn. Advertising budgets fluctuate, but physician attention does not. Hospitals and pharma value access to trusted clinical audiences more than raw reach. The platform is asset-light, throwing off cash even in softer ad markets. Investors fixate on growth deceleration and ignore margin durability. Product expansion deepens engagement without bloating costs. Network effects strengthen as usage compounds. This is professional attention monetization, not social media noise.” | BULL | Q4 2025 Dec 31, 2025 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
